Herba cistanches tablet and method for preparing same

A technology of Cistanche deserticola tablets and Cistanche deserticola is applied in the directions of pharmaceutical formulations, medical preparations containing active ingredients, plant raw materials, etc., to achieve the effects of enhancing immunity, improving sexual function, and improving drug efficacy.

Inactive Publication Date: 2018-05-25
浙江大晟药业有限公司
4 Cites 0 Cited by

AI-Extracted Technical Summary

Problems solved by technology

However, the existing Cistanche products of...
View more

Abstract

The invention discloses a herba cistanches tablet and a method for preparing the same. The herba cistanches tablet comprises, by weight, 100-155 parts of herba cistanches, 14-45 parts of cordyceps militaris, 50-100 parts of starch, 1-8 parts of radix polygoni multiflori, 1-7 parts of cortex eucommiae, 4-11 parts of rhizoma dioscoreae, 3-22 parts of semen euryales and 4-17 parts of fructus lycii. The herba cistanches tablet and the method have the advantages that diversified traditional Chinese medicines and the herba cistanches are mixed with one another to obtain the herba cistanches tablet,and accordingly the efficacy of the herba cistanches can be greatly improved; the herba cistanches tablet is free of optional side effects, and effects of nourishing beauty, regulating the endocrine,promoting the metabolism, enhancing the immunity, strengthening middle warmer, benefiting vital energy, improving sexual functions, resisting senescence, nourishing yin and tonifying blood can be realized by the herba cistanches tablet.

Application Domain

Organic active ingredientsDigestive system +8

Technology Topic

CordycepsSide effect +7

Examples

  • Experimental program(2)
  • Effect test(1)

Example Embodiment

[0014] Example 1
[0015] The Cistanche cistanche tablet of the present invention is composed of the following ingredients in parts by weight: 100 parts of cistanche, 14 parts of Cordyceps militaris, 50 parts of starch, 1 part of Polygonum multiflorum, 1 part of Eucommia ulmoides, 4 parts of Chinese yam, 3 parts of ginseng and 4 servings of wolfberry.
[0016] The preparation process of the Cistanche Tablets is as follows:
[0017] 1) Extract 14 parts of Cordyceps militaris, 1 part of Polygonum militaris, 1 part of Eucommia ulmoides, 4 parts of Chinese yam, 3 parts of Gorgon and 4 parts of Chinese wolfberry according to parts by weight. Wash, dry, mix and grind into powder;
[0018] 2) Extract 100 parts of Cistanche cistanche and 50 parts of starch and mix by weight;
[0019] 3) Extract the mixed powders of step 1 and step 2 and stir, and filter them after uniform mixing;
[0020] 4) Extract the sieved material of step 3 and use conventional methods to make tablets.

Example Embodiment

[0021] Example 2
[0022] The difference from Example 1 is that the Cistanche tablet is composed of the following ingredients in parts by weight: 155 parts of Cistanche, 45 parts of Cordyceps militaris, 100 parts of starch, 8 parts of Polygonum multiflorum, 7 parts of Eucommia ulmoides, 11 parts of yam, and 22 parts of Gorgon. Servings and 17 servings of wolfberry.

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Bacillus subtillis HMB28948 and application thereof

ActiveCN107043721AImprove efficacyStrong drug effect
Owner:INST OF PLANT PROTECTION HEBEI ACAD OF AGRI & FORESTRY SCI

Honeysuckle-scutellaria baicalensis-forsythia superfine powder and production method thereof

InactiveCN103463203AFast crushingImprove efficacy
Owner:SICHUAN LONGHAIYANG ANIMAL PHARMA CO LTD

Decitabine sustained release microsphere and preparation method thereof

ActiveCN101966157AExtended half-lifeImprove efficacy
Owner:苏州科耐尔医药科技有限公司

Novel Skin Remodeling Strategy

InactiveUS20160243023A1improve efficacy
Owner:ELC MANAGEMENT LLC

Classification and recommendation of technical efficacy words

  • regulate endocrine
  • Improve efficacy

Mixed glue radiating infrared rays and emitting negative ions and respirator coated with same

InactiveCN102061094Aregulate endocrineImprove basal metabolism
Owner:李贵列

Beauty-maintaining flower jellies and preparation method thereof

InactiveCN104286622Abright colorsregulate endocrine
Owner:QINGDAO DIANSHI STATIONERY

Yi-recipe meridian and collateral type fat and internal secretion regulating medicine bag

InactiveCN108853324APromote fat metabolismregulate endocrine
Owner:宣威市彝方化妆品有限公司

Traditional Chinese medicine composition for treating mammary gland fibroma and mammary gland hyperplasia and preparation method thereof

InactiveCN113144049Aregulate endocrineimprove immune function
Owner:贵州恒生源药业有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products